

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.60591520 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.94117925 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.94117925 |
| 4 | leukocyte aggregation (GO:0070486) | 5.85432012 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.83359167 |
| 6 | negative T cell selection (GO:0043383) | 5.73345542 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.64752884 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.64752884 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.64062692 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.54065523 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.18829760 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.98769528 |
| 13 | T cell migration (GO:0072678) | 4.93603882 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.85332461 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.83186890 |
| 16 | GDP-mannose metabolic process (GO:0019673) | 4.78469356 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.70483203 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.62485322 |
| 19 | response to interleukin-15 (GO:0070672) | 4.58290962 |
| 20 | thymic T cell selection (GO:0045061) | 4.47015836 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.43227362 |
| 22 | positive T cell selection (GO:0043368) | 4.40615678 |
| 23 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.16915604 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.15542047 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 4.13318606 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12668314 |
| 27 | T cell selection (GO:0045058) | 4.10323341 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.07773719 |
| 29 | interferon-gamma production (GO:0032609) | 3.99384763 |
| 30 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.99353692 |
| 31 | positive regulation of isotype switching (GO:0045830) | 3.98595981 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.96828885 |
| 33 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.96105261 |
| 34 | lymphocyte costimulation (GO:0031294) | 3.95229397 |
| 35 | T cell costimulation (GO:0031295) | 3.92325311 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.85846211 |
| 37 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.84208740 |
| 38 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.83286341 |
| 39 | regulation of response to interferon-gamma (GO:0060330) | 3.82008928 |
| 40 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.76550355 |
| 41 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.75681657 |
| 42 | positive regulation of DNA recombination (GO:0045911) | 3.71578765 |
| 43 | mast cell activation (GO:0045576) | 3.70963167 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.70730163 |
| 45 | adenosine receptor signaling pathway (GO:0001973) | 3.62785489 |
| 46 | regulation of chromatin binding (GO:0035561) | 3.62531212 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.61694537 |
| 48 | leukocyte cell-cell adhesion (GO:0007159) | 3.59021448 |
| 49 | modulation by virus of host process (GO:0019054) | 3.57188599 |
| 50 | response to peptidoglycan (GO:0032494) | 3.56486316 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55155812 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.55003823 |
| 53 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.53774264 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50328966 |
| 55 | regulation of isotype switching (GO:0045191) | 3.50004867 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.40026649 |
| 57 | base-excision repair, AP site formation (GO:0006285) | 3.37563908 |
| 58 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.34940014 |
| 59 | positive regulation of B cell mediated immunity (GO:0002714) | 3.34940014 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34596879 |
| 61 | pentose metabolic process (GO:0019321) | 3.34320545 |
| 62 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.34121243 |
| 63 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.32478886 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.31680583 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.31424979 |
| 66 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31111662 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29693106 |
| 68 | activated T cell proliferation (GO:0050798) | 3.29225394 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 3.28854568 |
| 70 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.26761736 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.25228551 |
| 72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.25228551 |
| 73 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.24186380 |
| 74 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.22544569 |
| 75 | regulation of B cell mediated immunity (GO:0002712) | 3.22284570 |
| 76 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20910934 |
| 77 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.20285104 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19549183 |
| 79 | negative regulation of phagocytosis (GO:0050765) | 3.19190305 |
| 80 | response to type I interferon (GO:0034340) | 3.18481575 |
| 81 | cellular extravasation (GO:0045123) | 3.17607757 |
| 82 | UV protection (GO:0009650) | 3.16473946 |
| 83 | cellular response to type I interferon (GO:0071357) | 3.15740439 |
| 84 | type I interferon signaling pathway (GO:0060337) | 3.15740439 |
| 85 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.14902487 |
| 86 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.13391262 |
| 87 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.13391262 |
| 88 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12483108 |
| 89 | deoxyribonucleotide catabolic process (GO:0009264) | 3.09236545 |
| 90 | rRNA modification (GO:0000154) | 3.09093621 |
| 91 | pentose-phosphate shunt (GO:0006098) | 3.08812072 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 3.08043532 |
| 93 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07444041 |
| 94 | response to protozoan (GO:0001562) | 3.07153456 |
| 95 | positive regulation of interleukin-2 production (GO:0032743) | 3.05414863 |
| 96 | proline biosynthetic process (GO:0006561) | 3.04489612 |
| 97 | natural killer cell activation (GO:0030101) | 3.02865223 |
| 98 | defense response to protozoan (GO:0042832) | 3.01809464 |
| 99 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98408513 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.98325468 |
| 101 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.98295085 |
| 102 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.97967530 |
| 103 | respiratory burst (GO:0045730) | 2.97607012 |
| 104 | positive regulation of humoral immune response (GO:0002922) | 2.97455177 |
| 105 | positive regulation of macrophage differentiation (GO:0045651) | 2.96089331 |
| 106 | T cell homeostasis (GO:0043029) | 2.96007999 |
| 107 | protein insertion into membrane (GO:0051205) | 2.93749075 |
| 108 | deoxyribose phosphate catabolic process (GO:0046386) | 2.93292353 |
| 109 | pyrimidine nucleoside salvage (GO:0043097) | 2.93151542 |
| 110 | pyrimidine-containing compound salvage (GO:0008655) | 2.93151542 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.92929309 |
| 112 | cellular defense response (GO:0006968) | 2.91653290 |
| 113 | modulation by symbiont of host cellular process (GO:0044068) | 2.91031565 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.90912580 |
| 115 | regulation of leukocyte degranulation (GO:0043300) | 2.90373997 |
| 116 | metallo-sulfur cluster assembly (GO:0031163) | 2.89857984 |
| 117 | iron-sulfur cluster assembly (GO:0016226) | 2.89857984 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88292309 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88292309 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.88292309 |
| 121 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88292309 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.88292309 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88292309 |
| 124 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88073034 |
| 125 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.87571430 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87175101 |
| 127 | lymphocyte migration (GO:0072676) | 2.86843865 |
| 128 | B cell mediated immunity (GO:0019724) | 2.85477705 |
| 129 | amino sugar catabolic process (GO:0046348) | 2.84423434 |
| 130 | leukocyte degranulation (GO:0043299) | 2.82397093 |
| 131 | regulation of superoxide anion generation (GO:0032928) | 2.81800612 |
| 132 | T-helper cell differentiation (GO:0042093) | 2.81566047 |
| 133 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.81566047 |
| 134 | T cell differentiation (GO:0030217) | 2.79828231 |
| 135 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.79592115 |
| 136 | alpha-beta T cell activation (GO:0046631) | 2.78935234 |
| 137 | neutrophil activation (GO:0042119) | 2.78076323 |
| 138 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77316716 |
| 139 | lymphocyte homeostasis (GO:0002260) | 2.77305913 |
| 140 | positive regulation of mast cell activation (GO:0033005) | 2.76583807 |
| 141 | ribosomal small subunit biogenesis (GO:0042274) | 2.74975342 |
| 142 | mannose metabolic process (GO:0006013) | 2.74523556 |
| 143 | positive regulation of protein homooligomerization (GO:0032464) | 2.74126753 |
| 144 | granulocyte activation (GO:0036230) | 2.73851931 |
| 145 | purinergic receptor signaling pathway (GO:0035587) | 2.73707997 |
| 146 | rRNA methylation (GO:0031167) | 2.73025554 |
| 147 | lipoxygenase pathway (GO:0019372) | 2.72733942 |
| 148 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.67428880 |
| 149 | mitochondrial calcium ion transport (GO:0006851) | 2.65997279 |
| 150 | cellular response to virus (GO:0098586) | 2.65937875 |
| 151 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63922969 |
| 152 | response to host immune response (GO:0052572) | 2.63922969 |
| 153 | NADPH regeneration (GO:0006740) | 2.60557979 |
| 154 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60019648 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.58442840 |
| 156 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.57665672 |
| 157 | negative regulation of innate immune response (GO:0045824) | 2.57474266 |
| 158 | N-acetylneuraminate metabolic process (GO:0006054) | 2.57367979 |
| 159 | detection of bacterium (GO:0016045) | 2.57194667 |
| 160 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.56856648 |
| 161 | granulocyte differentiation (GO:0030851) | 2.54187560 |
| 162 | negative regulation of B cell apoptotic process (GO:0002903) | 2.51237601 |
| 163 | response to muramyl dipeptide (GO:0032495) | 2.50612893 |
| 164 | tolerance induction (GO:0002507) | 2.50094262 |
| 165 | detection of other organism (GO:0098543) | 2.49808962 |
| 166 | regulated secretory pathway (GO:0045055) | 2.47851764 |
| 167 | nucleotide salvage (GO:0043173) | 2.47423619 |
| 168 | mitochondrial fusion (GO:0008053) | 2.46933559 |
| 169 | pinocytosis (GO:0006907) | 2.46018183 |
| 170 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.45884545 |
| 171 | transcription from mitochondrial promoter (GO:0006390) | 2.45112888 |
| 172 | macrophage activation involved in immune response (GO:0002281) | 2.44220818 |
| 173 | pseudouridine synthesis (GO:0001522) | 2.42835316 |
| 174 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.41286131 |
| 175 | response to host (GO:0075136) | 2.41286131 |
| 176 | response to host defenses (GO:0052200) | 2.41286131 |
| 177 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.40816453 |
| 178 | positive regulation of mast cell degranulation (GO:0043306) | 2.40816453 |
| 179 | regulation of regulated secretory pathway (GO:1903305) | 2.38319522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41748161 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.97082776 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.91901233 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.14158494 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09639353 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.99760841 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.58427589 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.39340814 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.37922247 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.36577834 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.29184012 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.99746727 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.87348572 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.79755241 |
| 15 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.78729158 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76414593 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71812970 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.63460680 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.59671639 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57462414 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55170055 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.54400875 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.49951599 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.45191326 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.43652672 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42879866 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41654985 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.38910213 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35593030 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34512803 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33845419 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.27189163 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15874696 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14839816 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09575684 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.05195170 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03514187 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93839313 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93302946 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90573150 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87834404 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85914436 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83679100 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82467609 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.76826172 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76481826 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75352813 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75344149 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.74493936 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.71870826 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.71077517 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.69678247 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69522955 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69026037 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66401642 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64818527 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.61728669 |
| 58 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61595722 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59932143 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59894490 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55768862 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54178865 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53977242 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53433900 |
| 65 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52814427 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52787506 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52135900 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51168564 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50495127 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.50241520 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48874947 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48544538 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47166324 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44865727 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44561433 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43372286 |
| 77 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.42114498 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40373424 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39245898 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38134224 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37918285 |
| 82 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37533528 |
| 83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.36983648 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34940853 |
| 85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34853866 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34367136 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31653630 |
| 88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29838907 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28519257 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27280392 |
| 91 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.27211857 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26399960 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25880417 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25410469 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25406413 |
| 96 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.24691852 |
| 97 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24388007 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21807989 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20768260 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20150245 |
| 101 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20097934 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19974396 |
| 103 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19942879 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19580492 |
| 105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15718811 |
| 106 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15558832 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15539160 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15482583 |
| 109 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14525583 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14087826 |
| 111 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14055108 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13398326 |
| 113 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13111578 |
| 114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12997908 |
| 115 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12371959 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12218762 |
| 117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11877339 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10945577 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10159160 |
| 120 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09919157 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08778422 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08444377 |
| 123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08346371 |
| 124 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07671981 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07114417 |
| 126 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06668379 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06568787 |
| 128 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04402745 |
| 129 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.01236051 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98852624 |
| 131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97551238 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96427541 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96039847 |
| 134 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94160478 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93959345 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91465758 |
| 137 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90008812 |
| 138 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89643141 |
| 139 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89012403 |
| 140 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.86584174 |
| 141 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86245192 |
| 142 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82784700 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81877961 |
| 144 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.80401192 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79579051 |
| 146 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77232787 |
| 147 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.76603542 |
| 148 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.76423358 |
| 149 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74443353 |
| 150 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73039277 |
| 151 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.72576393 |
| 152 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.71713011 |
| 153 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69928074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.54832947 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.05321024 |
| 3 | MP0005671_abnormal_response_to | 3.71556181 |
| 4 | MP0009785_altered_susceptibility_to | 3.47679303 |
| 5 | MP0000685_abnormal_immune_system | 3.12423882 |
| 6 | MP0006082_CNS_inflammation | 3.08152612 |
| 7 | MP0001800_abnormal_humoral_immune | 3.07285121 |
| 8 | MP0002420_abnormal_adaptive_immunity | 2.97553501 |
| 9 | MP0001819_abnormal_immune_cell | 2.94459272 |
| 10 | MP0005387_immune_system_phenotype | 2.91958345 |
| 11 | MP0001790_abnormal_immune_system | 2.91958345 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.89421573 |
| 13 | MP0005025_abnormal_response_to | 2.85683698 |
| 14 | MP0003436_decreased_susceptibility_to | 2.82089298 |
| 15 | MP0008260_abnormal_autophagy | 2.81979298 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.81648052 |
| 17 | MP0002723_abnormal_immune_serum | 2.79395810 |
| 18 | MP0002398_abnormal_bone_marrow | 2.70699613 |
| 19 | MP0003724_increased_susceptibility_to | 2.67235071 |
| 20 | MP0005083_abnormal_biliary_tract | 2.59463144 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.58057389 |
| 22 | MP0002419_abnormal_innate_immunity | 2.55015909 |
| 23 | MP0002405_respiratory_system_inflammati | 2.52145148 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.48582794 |
| 25 | MP0000716_abnormal_immune_system | 2.43224881 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.41676209 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.39153885 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.18870949 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.14694782 |
| 30 | MP0000703_abnormal_thymus_morphology | 2.13634323 |
| 31 | MP0002722_abnormal_immune_system | 2.12841608 |
| 32 | MP0004510_myositis | 2.10501823 |
| 33 | MP0002429_abnormal_blood_cell | 1.99914232 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.98839073 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.96001551 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.93163912 |
| 37 | MP0004947_skin_inflammation | 1.91589327 |
| 38 | MP0003303_peritoneal_inflammation | 1.88262181 |
| 39 | MP0009840_abnormal_foam_cell | 1.86589288 |
| 40 | MP0002132_abnormal_respiratory_system | 1.85900742 |
| 41 | MP0002933_joint_inflammation | 1.84572964 |
| 42 | MP0005310_abnormal_salivary_gland | 1.83846215 |
| 43 | MP0000858_altered_metastatic_potential | 1.83556323 |
| 44 | MP0001851_eye_inflammation | 1.81706635 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.80897422 |
| 46 | MP0001873_stomach_inflammation | 1.79395188 |
| 47 | MP0002006_tumorigenesis | 1.70685816 |
| 48 | MP0003866_abnormal_defecation | 1.59359325 |
| 49 | MP0005501_abnormal_skin_physiology | 1.54716499 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.51449241 |
| 51 | MP0001853_heart_inflammation | 1.45327375 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.39361977 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.39361977 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.39241452 |
| 55 | MP0003448_altered_tumor_morphology | 1.38482554 |
| 56 | MP0008469_abnormal_protein_level | 1.36795510 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.34156923 |
| 58 | MP0000490_abnormal_crypts_of | 1.33067857 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.27597164 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.26943055 |
| 61 | MP0004957_abnormal_blastocyst_morpholog | 1.23747711 |
| 62 | MP0009278_abnormal_bone_marrow | 1.23288311 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.20917721 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.18976193 |
| 65 | MP0009764_decreased_sensitivity_to | 1.15985579 |
| 66 | MP0008004_abnormal_stomach_pH | 1.15956347 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.13080776 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.12240257 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.10103666 |
| 70 | MP0008058_abnormal_DNA_repair | 1.02734484 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.01469728 |
| 72 | MP0000358_abnormal_cell_content/ | 0.98514216 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.98402847 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.97631686 |
| 75 | MP0005171_absent_coat_pigmentation | 0.96431502 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.95724381 |
| 77 | MP0008932_abnormal_embryonic_tissue | 0.93460658 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.92765977 |
| 79 | MP0004381_abnormal_hair_follicle | 0.89871411 |
| 80 | MP0000750_abnormal_muscle_regeneration | 0.89799087 |
| 81 | MP0001849_ear_inflammation | 0.89654517 |
| 82 | MP0002796_impaired_skin_barrier | 0.86914064 |
| 83 | MP0003075_altered_response_to | 0.85974959 |
| 84 | MP0003279_aneurysm | 0.84266578 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83455416 |
| 86 | MP0008874_decreased_physiological_sensi | 0.83241567 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.82714978 |
| 88 | MP0009931_abnormal_skin_appearance | 0.81122467 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.80581160 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.80299211 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.79959772 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.79736176 |
| 93 | MP0003111_abnormal_nucleus_morphology | 0.78694029 |
| 94 | MP0000343_altered_response_to | 0.78448794 |
| 95 | MP0003077_abnormal_cell_cycle | 0.75819368 |
| 96 | MP0001730_embryonic_growth_arrest | 0.75794115 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.75030160 |
| 98 | MP0001764_abnormal_homeostasis | 0.74852005 |
| 99 | MP0005360_urolithiasis | 0.74398603 |
| 100 | MP0003828_pulmonary_edema | 0.74340295 |
| 101 | MP0005166_decreased_susceptibility_to | 0.74087726 |
| 102 | MP0005023_abnormal_wound_healing | 0.72905676 |
| 103 | MP0003693_abnormal_embryo_hatching | 0.71825069 |
| 104 | MP0009763_increased_sensitivity_to | 0.71494554 |
| 105 | MP0005451_abnormal_body_composition | 0.71296743 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.70954651 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.70388216 |
| 108 | MP0005390_skeleton_phenotype | 0.70038850 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69862786 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.65975517 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.64736229 |
| 112 | MP0000313_abnormal_cell_death | 0.63526825 |
| 113 | MP0003795_abnormal_bone_structure | 0.62801109 |
| 114 | MP0010307_abnormal_tumor_latency | 0.60553607 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.59274805 |
| 116 | MP0003786_premature_aging | 0.58859994 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.57553999 |
| 118 | MP0000371_diluted_coat_color | 0.55634065 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.51079845 |
| 120 | MP0001191_abnormal_skin_condition | 0.47124675 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.46521979 |
| 122 | MP0000249_abnormal_blood_vessel | 0.45877869 |
| 123 | MP0001663_abnormal_digestive_system | 0.45857208 |
| 124 | MP0008873_increased_physiological_sensi | 0.45483718 |
| 125 | MP0002928_abnormal_bile_duct | 0.44682225 |
| 126 | MP0006292_abnormal_olfactory_placode | 0.42176471 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.41935623 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.40711176 |
| 129 | MP0003186_abnormal_redox_activity | 0.39025557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.05472176 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.99844191 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.95922315 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85076809 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.84605831 |
| 6 | Abnormality of T cells (HP:0002843) | 4.55572593 |
| 7 | IgM deficiency (HP:0002850) | 4.48354646 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.23994109 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.12154062 |
| 10 | Myositis (HP:0100614) | 3.88620300 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.87255509 |
| 12 | Stomatitis (HP:0010280) | 3.87224540 |
| 13 | Recurrent viral infections (HP:0004429) | 3.85205012 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.84806413 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.73607744 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.73607744 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.73139172 |
| 18 | Chronic otitis media (HP:0000389) | 3.70992934 |
| 19 | IgG deficiency (HP:0004315) | 3.66111949 |
| 20 | Severe combined immunodeficiency (HP:0004430) | 3.59269079 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57060575 |
| 22 | Obstructive lung disease (HP:0006536) | 3.57060575 |
| 23 | Testicular atrophy (HP:0000029) | 3.52991370 |
| 24 | Combined immunodeficiency (HP:0005387) | 3.52760381 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.45768864 |
| 26 | Lymphopenia (HP:0001888) | 3.44039493 |
| 27 | Nasal polyposis (HP:0100582) | 3.40687330 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.37537458 |
| 29 | Recurrent skin infections (HP:0001581) | 3.32071434 |
| 30 | Meningitis (HP:0001287) | 3.28789185 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.28413827 |
| 32 | Increased IgM level (HP:0003496) | 3.27697125 |
| 33 | Ragged-red muscle fibers (HP:0003200) | 3.23048542 |
| 34 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.21964219 |
| 35 | Purpura (HP:0000979) | 3.21886489 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.20523479 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17068860 |
| 38 | Thrombocytosis (HP:0001894) | 3.15495649 |
| 39 | Leukocytosis (HP:0001974) | 3.15090102 |
| 40 | Epistaxis (HP:0000421) | 3.10599281 |
| 41 | Thoracic kyphosis (HP:0002942) | 3.05481512 |
| 42 | Prolonged bleeding time (HP:0003010) | 3.04258664 |
| 43 | Vaginal fistula (HP:0004320) | 3.03592562 |
| 44 | Thyroiditis (HP:0100646) | 2.94084723 |
| 45 | Chronic diarrhea (HP:0002028) | 2.90779680 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.90209800 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.87527117 |
| 48 | Rectovaginal fistula (HP:0000143) | 2.86713099 |
| 49 | Rectal fistula (HP:0100590) | 2.86713099 |
| 50 | Pustule (HP:0200039) | 2.86530129 |
| 51 | Vasculitis (HP:0002633) | 2.86358679 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.85758224 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.84336489 |
| 54 | Encephalitis (HP:0002383) | 2.78477571 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.78143890 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.75712675 |
| 57 | Orchitis (HP:0100796) | 2.73943981 |
| 58 | Eosinophilia (HP:0001880) | 2.73833260 |
| 59 | Intestinal fistula (HP:0100819) | 2.72569996 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.67489120 |
| 61 | Optic neuritis (HP:0100653) | 2.67489120 |
| 62 | Gingivitis (HP:0000230) | 2.67264347 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.63693908 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.63054611 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 2.61139432 |
| 66 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.60501161 |
| 67 | Annular pancreas (HP:0001734) | 2.60092262 |
| 68 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.57991383 |
| 69 | Dyschromatopsia (HP:0007641) | 2.57787773 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.57105859 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.55884157 |
| 72 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54030544 |
| 73 | Joint swelling (HP:0001386) | 2.53051191 |
| 74 | Progressive muscle weakness (HP:0003323) | 2.49663453 |
| 75 | Increased serum ferritin (HP:0003281) | 2.49516595 |
| 76 | Progressive external ophthalmoplegia (HP:0000590) | 2.47791108 |
| 77 | Gingival bleeding (HP:0000225) | 2.46494718 |
| 78 | Entropion (HP:0000621) | 2.45347909 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.44690848 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.44040190 |
| 81 | Hemoptysis (HP:0002105) | 2.43458052 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.42681589 |
| 83 | Abnormal platelet function (HP:0011869) | 2.42681589 |
| 84 | Hypertensive crisis (HP:0100735) | 2.42159706 |
| 85 | Chest pain (HP:0100749) | 2.42159357 |
| 86 | Petechiae (HP:0000967) | 2.40747754 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.39568969 |
| 88 | Arterial thrombosis (HP:0004420) | 2.39094658 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.38517442 |
| 90 | Recurrent sinusitis (HP:0011108) | 2.37845241 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.37137051 |
| 92 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.36658820 |
| 93 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.36658820 |
| 94 | Granulocytopenia (HP:0001913) | 2.36350694 |
| 95 | Joint hemorrhage (HP:0005261) | 2.36282720 |
| 96 | Spontaneous hematomas (HP:0007420) | 2.34389080 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.31665554 |
| 98 | Squamous cell carcinoma (HP:0002860) | 2.28182071 |
| 99 | Thin bony cortex (HP:0002753) | 2.28140109 |
| 100 | Loss of speech (HP:0002371) | 2.24886602 |
| 101 | Lymphoma (HP:0002665) | 2.23851941 |
| 102 | Abnormal trabecular bone morphology (HP:0100671) | 2.23502515 |
| 103 | Pulmonary infiltrates (HP:0002113) | 2.22834846 |
| 104 | Myopathic facies (HP:0002058) | 2.22540760 |
| 105 | Cellulitis (HP:0100658) | 2.20762600 |
| 106 | Respiratory difficulties (HP:0002880) | 2.20136059 |
| 107 | Amaurosis fugax (HP:0100576) | 2.19800062 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.17406375 |
| 109 | Urticaria (HP:0001025) | 2.15318697 |
| 110 | Increased IgE level (HP:0003212) | 2.11635441 |
| 111 | Microretrognathia (HP:0000308) | 2.10279882 |
| 112 | Reduced antithrombin III activity (HP:0001976) | 2.09931980 |
| 113 | Poikiloderma (HP:0001029) | 2.07554986 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 2.06434240 |
| 115 | Abnormality of the thoracic spine (HP:0100711) | 2.05655724 |
| 116 | Menorrhagia (HP:0000132) | 2.03994929 |
| 117 | Chronic sinusitis (HP:0011109) | 2.03267689 |
| 118 | Viral hepatitis (HP:0006562) | 2.01724470 |
| 119 | Periodontitis (HP:0000704) | 2.00766767 |
| 120 | Bronchitis (HP:0012387) | 1.99915677 |
| 121 | Mesangial abnormality (HP:0001966) | 1.99407412 |
| 122 | Hypoplasia of the thymus (HP:0000778) | 1.98297795 |
| 123 | Abnormality of the fingertips (HP:0001211) | 1.98048667 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96918450 |
| 125 | Hypochromic anemia (HP:0001931) | 1.96855503 |
| 126 | Albinism (HP:0001022) | 1.95799411 |
| 127 | Anorexia (HP:0002039) | 1.94361308 |
| 128 | Abnormal platelet volume (HP:0011876) | 1.93400323 |
| 129 | Keratoconjunctivitis sicca (HP:0001097) | 1.92662549 |
| 130 | Male infertility (HP:0003251) | 1.92545049 |
| 131 | Easy fatigability (HP:0003388) | 1.91720525 |
| 132 | Skin ulcer (HP:0200042) | 1.90142355 |
| 133 | Increased mean platelet volume (HP:0011877) | 1.89750952 |
| 134 | B lymphocytopenia (HP:0010976) | 1.89662959 |
| 135 | Abnormality of B cell number (HP:0010975) | 1.89662959 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88107695 |
| 137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88107695 |
| 138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88107695 |
| 139 | Abnormal hair whorl (HP:0010721) | 1.87933023 |
| 140 | Colitis (HP:0002583) | 1.87576187 |
| 141 | Abnormality of the costochondral junction (HP:0000919) | 1.87209598 |
| 142 | Abnormality of the intrinsic pathway (HP:0010989) | 1.86684607 |
| 143 | Acrocyanosis (HP:0001063) | 1.86539780 |
| 144 | Glomerulopathy (HP:0100820) | 1.85344465 |
| 145 | Premature graying of hair (HP:0002216) | 1.85329326 |
| 146 | Increased cerebral lipofuscin (HP:0011813) | 1.85229388 |
| 147 | Cholelithiasis (HP:0001081) | 1.84834359 |
| 148 | Abnormality of DNA repair (HP:0003254) | 1.84657502 |
| 149 | Abnormality of lateral ventricle (HP:0030047) | 1.83952140 |
| 150 | Basal ganglia calcification (HP:0002135) | 1.83241210 |
| 151 | Breast hypoplasia (HP:0003187) | 1.80773011 |
| 152 | IgA deficiency (HP:0002720) | 1.80490001 |
| 153 | Microvesicular hepatic steatosis (HP:0001414) | 1.80248149 |
| 154 | Rib fusion (HP:0000902) | 1.79743456 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.79325719 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79325719 |
| 157 | Ulnar bowing (HP:0003031) | 1.78293904 |
| 158 | Muscle fiber atrophy (HP:0100295) | 1.78132839 |
| 159 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78128601 |
| 160 | Increased hepatocellular lipid droplets (HP:0006565) | 1.76454703 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.76198582 |
| 162 | Cholecystitis (HP:0001082) | 1.76198582 |
| 163 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.73641116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.19016570 |
| 2 | MAP4K1 | 5.00735782 |
| 3 | JAK3 | 3.10924866 |
| 4 | ZAP70 | 2.96876669 |
| 5 | TAOK2 | 2.92668240 |
| 6 | PRPF4B | 2.69636968 |
| 7 | SMG1 | 2.69079524 |
| 8 | IKBKE | 2.52523541 |
| 9 | MAP3K11 | 2.49424020 |
| 10 | TYK2 | 2.37919881 |
| 11 | STK10 | 2.37021402 |
| 12 | KIT | 2.33579391 |
| 13 | MAP3K14 | 2.29780122 |
| 14 | ITK | 2.27919315 |
| 15 | IRAK4 | 2.20843757 |
| 16 | BLK | 2.05104450 |
| 17 | TEC | 2.01839205 |
| 18 | BTK | 1.91500760 |
| 19 | MAP3K12 | 1.89761325 |
| 20 | TRIB3 | 1.85205486 |
| 21 | LCK | 1.84069292 |
| 22 | MST4 | 1.83646221 |
| 23 | CLK1 | 1.81840061 |
| 24 | TBK1 | 1.79278383 |
| 25 | GRK6 | 1.69950647 |
| 26 | VRK2 | 1.69142136 |
| 27 | SYK | 1.68058431 |
| 28 | CSF1R | 1.58045443 |
| 29 | HCK | 1.55011221 |
| 30 | NME2 | 1.54126472 |
| 31 | JAK1 | 1.52528951 |
| 32 | MARK3 | 1.51195537 |
| 33 | SIK3 | 1.50893345 |
| 34 | IKBKB | 1.48793466 |
| 35 | SIK1 | 1.44746314 |
| 36 | CSK | 1.41487287 |
| 37 | MAP2K6 | 1.40351597 |
| 38 | NLK | 1.40061803 |
| 39 | TESK1 | 1.39768495 |
| 40 | NEK9 | 1.37457535 |
| 41 | FES | 1.33533598 |
| 42 | EPHA3 | 1.33485953 |
| 43 | FGFR4 | 1.32731363 |
| 44 | BMX | 1.29599667 |
| 45 | TESK2 | 1.27108317 |
| 46 | MAP3K3 | 1.26615612 |
| 47 | EPHA2 | 1.24263679 |
| 48 | BUB1 | 1.18351476 |
| 49 | PRKD2 | 1.16540581 |
| 50 | AURKA | 1.13118180 |
| 51 | KDR | 1.13009406 |
| 52 | ARAF | 1.11405959 |
| 53 | MAP3K13 | 1.07331515 |
| 54 | STK16 | 1.06803349 |
| 55 | ICK | 1.06743301 |
| 56 | MAPK15 | 1.04272482 |
| 57 | PIM1 | 1.04113271 |
| 58 | LYN | 1.03502208 |
| 59 | ACVR1B | 0.99665794 |
| 60 | BCKDK | 0.99173492 |
| 61 | TAOK3 | 0.97899204 |
| 62 | TGFBR2 | 0.94452122 |
| 63 | MAP3K5 | 0.94264522 |
| 64 | IRAK3 | 0.92701792 |
| 65 | MAP3K1 | 0.91534059 |
| 66 | PRKCQ | 0.89910516 |
| 67 | FGFR3 | 0.88104498 |
| 68 | DYRK1B | 0.84950701 |
| 69 | VRK1 | 0.83512552 |
| 70 | MATK | 0.81432628 |
| 71 | PAK1 | 0.81322252 |
| 72 | PDPK1 | 0.81080936 |
| 73 | PRKCH | 0.79722948 |
| 74 | CHUK | 0.78677659 |
| 75 | RPS6KA4 | 0.78387395 |
| 76 | FLT3 | 0.74439948 |
| 77 | MAP3K6 | 0.73888409 |
| 78 | CDK4 | 0.71331634 |
| 79 | TLK1 | 0.71205756 |
| 80 | MAP2K3 | 0.70934311 |
| 81 | TGFBR1 | 0.70437948 |
| 82 | MAP3K8 | 0.69607353 |
| 83 | MST1R | 0.68403607 |
| 84 | LRRK2 | 0.67883264 |
| 85 | RPS6KA6 | 0.67825329 |
| 86 | PAK4 | 0.66624876 |
| 87 | MARK2 | 0.65762001 |
| 88 | MAP2K2 | 0.65731475 |
| 89 | DAPK1 | 0.65525728 |
| 90 | TNK2 | 0.63458732 |
| 91 | JAK2 | 0.58406592 |
| 92 | MAP2K4 | 0.57674236 |
| 93 | ERN1 | 0.57069400 |
| 94 | STK4 | 0.56190172 |
| 95 | PIM2 | 0.55439680 |
| 96 | BMPR1B | 0.54519534 |
| 97 | CDK7 | 0.54309396 |
| 98 | SIK2 | 0.53695248 |
| 99 | ABL2 | 0.53422520 |
| 100 | SCYL2 | 0.51995958 |
| 101 | PBK | 0.51334627 |
| 102 | MAPK12 | 0.49969594 |
| 103 | ADRBK2 | 0.48934586 |
| 104 | PDK2 | 0.47840328 |
| 105 | SRPK1 | 0.47096085 |
| 106 | BRSK2 | 0.46781678 |
| 107 | RAF1 | 0.46758446 |
| 108 | ALK | 0.46307943 |
| 109 | CDK12 | 0.44858358 |
| 110 | RIPK4 | 0.44424054 |
| 111 | PDK1 | 0.43726454 |
| 112 | TAOK1 | 0.41867231 |
| 113 | RPS6KL1 | 0.41835771 |
| 114 | RPS6KC1 | 0.41835771 |
| 115 | PTK6 | 0.41147090 |
| 116 | MAP2K7 | 0.41026328 |
| 117 | IRAK2 | 0.39873545 |
| 118 | SGK2 | 0.39726644 |
| 119 | SGK3 | 0.39546870 |
| 120 | CHEK2 | 0.37659800 |
| 121 | DAPK3 | 0.37520133 |
| 122 | PRKG2 | 0.37401063 |
| 123 | PRKD1 | 0.36933814 |
| 124 | KSR2 | 0.36229697 |
| 125 | DMPK | 0.35853377 |
| 126 | CCNB1 | 0.35169233 |
| 127 | PRKCD | 0.34614757 |
| 128 | MAP3K10 | 0.33222777 |
| 129 | CDK19 | 0.33022860 |
| 130 | MAPK3 | 0.32984893 |
| 131 | MAPK4 | 0.32089955 |
| 132 | ABL1 | 0.30051135 |
| 133 | CDC7 | 0.28560356 |
| 134 | WEE1 | 0.28553697 |
| 135 | IGF1R | 0.27747472 |
| 136 | NUAK1 | 0.26770085 |
| 137 | FGR | 0.26653993 |
| 138 | STK24 | 0.25210744 |
| 139 | IRAK1 | 0.23302282 |
| 140 | HIPK2 | 0.23130088 |
| 141 | ATR | 0.23041166 |
| 142 | EIF2AK1 | 0.22982227 |
| 143 | EPHB1 | 0.22943798 |
| 144 | MAPK11 | 0.22263351 |
| 145 | MAPKAPK2 | 0.22135657 |
| 146 | FYN | 0.21921985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.31141059 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.08544912 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78192706 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.72797427 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.64056706 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.59005135 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.58225183 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.52014934 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.50159099 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49263923 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.22148179 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.13612683 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.13115961 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09610069 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.07822954 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04922699 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92240666 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75136634 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68533309 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63225540 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60745750 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.58404948 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56185981 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49274512 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49233004 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45870363 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44880320 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42223180 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37982002 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37935439 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.36618282 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.35270915 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.33913399 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.29180303 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29114353 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28164723 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26358594 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.25494307 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25429261 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.25191880 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.24832900 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24792513 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23051750 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23000873 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.21878589 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18753444 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.18743370 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17716016 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11634512 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06804553 |
| 51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06122591 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.04244732 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.03661227 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02176704 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00691313 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.99839099 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98994198 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97761547 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96118488 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.91387259 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86788180 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85143151 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83268504 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.81407868 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80421894 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.79109010 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.78347220 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.77867660 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.77062072 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77027739 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.74671180 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74653288 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73820962 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73307761 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.70610436 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70055678 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69849027 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69199827 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68443941 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68249890 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68054768 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67990936 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65189172 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64735801 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.62776210 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62661033 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62334521 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61808635 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61686317 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61615153 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61336101 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61148933 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61061593 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60375262 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57835198 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57061718 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56836869 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56112942 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55954398 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55836007 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.54693722 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54397954 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53691616 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.53639121 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53069197 |
| 106 | Cell cycle_Homo sapiens_hsa04110 | 0.52732691 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52434577 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51264321 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50677013 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50002242 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49876638 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49591359 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.49131827 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48347135 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47086812 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46418574 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45477880 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45459723 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44667617 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44511565 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44352528 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40867012 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35854744 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35595199 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34565354 |
| 126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33121480 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27172493 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25215419 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.23499573 |

